No Detail Found!

Association of Serum Alpha Fetoprotein (AFP) Levels with Size of Hepatocellular Carcinoma.

Author(s)
Khawar Shabbir Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Asim Shehzad Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Mehdi Naqvi Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Muhammad Sohail Khalid Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Nadeem Zia Combined Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Ehtesham Haider Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Asif Farooq Pak Emirates Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi, Pakistan
Abstract
Objective: To determine the association between high levels of serum Alpha Fetoprotein (AFP) and tumor size in hepatocellular carcinoma (HCC). Study Design: Cross-sectional analytical study. Place and Duration of Study: Department of Gastroenterology and Hepatology, Pak Emirates Military Hospital, Rawalpindi from June 2015 to June 2017. Material and Methods: Two hundred and thirty six patients diagnosed with HCC were enrolled in the study, out of which 175 provided the required data to perform the association. All demographic data and clinical information was recorded on a predesigned proforma, after taking proper informed consent. The cases were divided into three groups for each variable to evaluate. Concerning the serum alpha fetoprotein levels, they were divided as group 1 (normal level: 400 UI/ml). According to the size of their tumors, the group A contains patients with less than 3 cm. tumors; in group B the tumors are 3 to 5cm. and the group C is formed by patients whose tumors were larger than 5 cm. Other variables such as number of lesions (tumors), Child Pugh and BCLC scores were considered as additional information. Results: Total 175 patients took part in final data analysis. The age range was from 30 to 85 years old. Considering their AFP levels, there were 61 in group 1, 75 in group 2 and 39 in group 3. In addition, according to their size of tumor, there were 28, 56 and 91 for group A, B and C respectively. A clear relationship between the AFP levels and the size of the tumors was noticed, especially for the group 2 and 3 with 55.4% and 56.4% respectively, in concordance with group B & C. Conclusion: No significant association was seen between Serum AFP levels and the size of tumor in HCC (p-value = 0.72).
Publication Details
Page(s) 71-75
DOI DOI not available
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 69, Issue: 1, Year: 2019

Request the full text from PASTIC

Keywords
Serum Alpha Fetoprotein, Tumor size
References
ButtAS,AbbasZ,JafriW. Hepatocellular, 2012.carcinoma in pakistan: where do we stand?,Hepatitis monthly 12 -
BaloghJ,EH , Burroughs,SG , Boktour,M , Saharia,A , Li,X , Ghobrial,RM, 2016.Hepatocellular carcinoma: A review,J Hepatocell Carcinoma 3 41 -
DavisGL,DempsterJ,MelerJD,OrrDW,WalbergMW,BrownB, 2008.Hepatocellular carcinoma: Management of an increasingly common problem,Proc (Bayl Univ Med Cent) 21 266 -80
ChedidF,KruelCR,PintoMA,Grezzana-filhoTJ,Brasileiros de Cirurgia Digestiva, 2017.Hepatocellular carcinoma: diagnosis and operative management, 30 272 -8
PatilM,ShethKA,AdarshCK, 2013.Elevated alpha fetoprotein, no hepatocellular carcinoma,J Clin Exp Hepatol 3 162 -4
SamiullahM,SharifS,FarhatS., 2016.Hepatocellular carcinoma; correlation of serum alpha fetoprotein and tumor size,Professional Med J 23 209 -12
AbbasiA,BhuttoAR,ButtN,MunirSM, 2012.Correlation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma,JPMA 62 33 -
SharieffS,BurneyIA,SalamA,SiddiquiT., 2001.Lack of correlation between alpha-fetoprotein and tumor size in hepatocellular carcinoma,JPMA 51 123 -4
HaqueI,ZafarS,IqbalW, 2015.Does Value of Alpha Fetoprotein Matter in HCC?,PJMHS 9 305 -07
LimAG,QureshiH,MahmoodH,HamidS,DaviesCF,TrickeyA, 2018.Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination,Int J Epidemiol 47 550 -60
MehtaNJ,CelikAD,PetersMG, 2017.Screening for hepatocellular carcinoma: What is missing?,Hepatology Communications 1 18 -22
MujeebSA,JamalQ,KhananiR,IqbalN,KaherS., 1997.Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma,Trop Doct 27 45 -6
KuboY,OkudaK,MushaH,NakashimaT., 1978.Detection of hepatocellular carcinoma during a clinical follow-up of chronic liver disease: observation in 31 patients,Gastroenterology 74 578 -82
OkaH,KuriokaN,KimK,KannoT,KurokiT,MizoguchiY, 1990.Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis,Hepatology 12 680 -7
ShinagawaT,OhtoM,KimuraK,TsunetomiS,MoritaM. Diagnosis, 1984.and clinical features of small hepatocellular carcinoma with emphasis on the utility of real-time ultrasono-graphy: a study in 51 patients,Gastroenterology 86 495 -502
AoyagiY,SuzukiY,IgarashiK,SaitohA,OguroM,YokotaT, 1993.Carbohydrate structures of human alpha-fetoprotein of patients with hepatocellular carcinoma: presence of fucosylated and non-fucosylatedtriantennaryglycans,Br J Cancer 67 486 -92
FornerA,LlovetJM,J., 2012.Hepatocellular carcinoma,Lancet 379 1245 -55
El-SeragHB,Kanwal , F., 2013.alpha-Fetoprotein in hepatocellular carcinoma surveillance: mend it but do not end it,Clin Gastroenterol Hepatol 11 441 -43
0

Citations

0

Downloads

97

Views